Prana Biotechnology (PRAN)
News
| May 09 | Prana Chief Scientific Advisor to Give Plenary Lecture at Alzheimer's Symposium in St... |
| May 01 | Prana Comments on Archives of Neurology Publication Which Highlights Critical Role of... |
| Apr 30 | Prana enrolls 1st patient in Reach2HD Phase II Huntington Disease trial |
| Apr 30 | Prana Enrolls First Patient in the "Reach2HD" Phase II Huntington Disease Trial Marketwire |
| Mar 26 | PLoS ONE Journal Publishes Mechanistic Model of Alzheimer's Disease Endorsing Prana's... |
| Mar 07 | Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial Benzinga |
| Feb 28 | $PRAN nice pop by tradueruski |
| Feb 10 | $PRAN lows by tradueruski |
| Feb 06 | $pran is climbing Mount Everest. Jump on everyone that follow me. Also $chtp $glng $cldx. Hurry! by JohnVan |
| Feb 03 | $PRAN http://stks.co/2EJ2 long setup by stt2318 |
| Nov 28 | $PRAN Secures Patent for Parkinson's Drug PBT434 in the US by Benzinga |
Profile
Exchange: NASDAQCM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Prana Biotechnology is down 18.37% over the last year vs S&P 500 Total Return up 0.88%, BioLineRx up 0.00%, and Achillion Pharmaceuticals down 5.21%.
- PRAN Total Returns
- ^SPXTR Total Returns
- BLRX Total Returns
- ACHN Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
You may also be interested in these PRAN related companies
Pro Strategies Featuring PRAN
Did Prana Biotechnology make it into our Pro Portfolio Strategies?
PRAN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other PRAN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PRAN | 1.60 | +0.00 | +0.00% | 44.05M |
| PRAA | 68.30 | -0.69 | -1.00% | 1.183B |
| PRA | 87.98 | -0.25 | -0.28% | 2.695B |
| PQ | 4.82 | -0.15 | -3.02% | 318.58M |
| PPT | 5.435 | -0.01 | -0.28% | |
| PPR | 5.54 | +0.00 | +0.00% | |
| PPO | 37.22 | -0.78 | -2.05% | 1.767B |
| PNBC | 0.7131 | -0.09 | -10.86% | 2.375M |
| PMTC | 19.99 | -0.48 | -2.34% | 2.438B |
| PMT | 18.21 | -0.24 | -1.30% | 554.61M |
